Nu Skin Enterprises (NYSE:NUS) Issues FY 2026 Earnings Guidance

Key Points

• FY 2026 EPS guidance is $0.55–$0.65, below analysts’ $0.82 consensus; revenue guidance of $1.3 billion matches estimates.
• Nu Skin’s latest quarter fell short of forecasts, reporting EPS of $0.10 versus $0.21 expected and revenue of $311.0 million versus $328.7 million expected. Shares dropped 4.6% in Friday trading.
• The company declared a quarterly dividend of $0.06 per share, equivalent to $0.24 annually and a stated yield of 5.6%.

Nu Skin Enterprises (NYSE:NUS - Get Free Report) issued an update on its FY 2026 earnings guidance on Friday morning. The company provided EPS guidance of 0.550-0.650 for the period, compared to the consensus estimate of 0.820. The company issued revenue guidance of $1.3 billion, compared to the consensus revenue estimate of $1.3 billion.

Wall Street Analyst Weigh In

A number of equities research analysts have commented on the company. Weiss Ratings cut Nu Skin Enterprises from a "sell (d+)" rating to a "sell (d)" rating in a research note on Tuesday, August 11th. Zacks Research upgraded Nu Skin Enterprises from a "strong sell" rating to a "hold" rating in a research report on Monday, October 12th. One equities research analyst has rated the stock with a Hold rating and one has assigned a Sell rating to the company. Based on data from MarketBeat.com, Nu Skin Enterprises presently has a consensus rating of "Reduce".

Nu Skin Enterprises Trading Down 4.6%

Shares of NYSE:NUS traded down $0.21 during mid-day trading on Friday, hitting $4.32. The company had a trading volume of 297,247 shares, compared to its average volume of 573,282. The firm has a fifty day moving average price of $4.77 and a 200 day moving average price of $6.30. The company has a market capitalization of $210.28 million, a PE ratio of -0.97 and a beta of 0.92. The company has a debt-to-equity ratio of 0.36, a current ratio of 1.98 and a quick ratio of 1.24. Nu Skin Enterprises has a one year low of $4.24 and a one year high of $11.67.

Nu Skin Enterprises (NYSE:NUS - Get Free Report) last released its quarterly earnings results on Friday, November 6th. The company reported $0.10 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.21 by ($0.11). The company had revenue of $311.01 million for the quarter, compared to analyst estimates of $328.70 million. Nu Skin Enterprises had a negative net margin of 15.73% and a positive return on equity of 6.58%. Nu Skin Enterprises has set its FY 2026 guidance at 0.550-0.650 EPS. As a group, research analysts forecast that Nu Skin Enterprises will post 0.82 EPS for the current year.

Nu Skin Enterprises Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, December 9th. Shareholders of record on Friday, November 27th will be given a $0.06 dividend. This represents a $0.24 dividend on an annualized basis and a yield of 5.6%. The ex-dividend date of this dividend is Friday, November 27th. Nu Skin Enterprises's dividend payout ratio is presently -5.37%.

Nu Skin Enterprises Company Profile

Nu Skin Enterprises, Inc is a global direct-selling company that develops and distributes personal care and wellness products. Its portfolio includes skincare, beauty and personal care products, nutritional supplements, and wellness-related devices and technologies. The company markets products under brands including Nu Skin and Pharmanex, with its ageLOC product line focused on skincare and age-related wellness.

Founded in 1984 and headquartered in Provo, Utah, Nu Skin sells its products primarily through a network of independent distributors, supported by digital commerce and other direct-to-consumer channels.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.